Thessalia Kamilari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Thessalia Kamilari has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Aggeliki Kolialexi
Department of Genetics, Institute of Child Health, 11527 Athens, Greece
1 shared publication - Christina Kanaka-Gantenbein
Postgraduate Program “The Science of Stress and Health Promotion”, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece
1 shared publication - Eirini Nikaina
1st Department of Pediatrics, Medical School, National and Kapodistrian University of Athens, “Agia Sophia” Children’s Hospital, 11527 Athens, Greece
1 shared publication - Eleftheria Dikoglou-Tzanetatou
Department of Genetics, Institute of Child Health, 11527 Athens, Greece
1 shared publication - Myrto Poulou
Department of Genetics, Institute of Child Health, 11527 Athens, Greece
1 shared publication - Tania Siahanidou
Neonatology Unit, First Department of Pediatrics, Medical School, National and Kapodistrian University of Athens, “Aghia Sophia” Children’s Hospital, 11527 Athens, Greece
1 shared publication
Latest Publications
- Open Access
- 7 May 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (10) , 4163
Wiedemann–Steiner Syndrome (WSS): A Neonatal Case Report Expanding the Phenotypic Spectrum of a Previously Reported Missense Variant
We present a neonatal case of Wiedemann–Steiner syndrome (WSS) with a de novo, previously reported KMT2A missense variant (c.3464G>A; p.Cys1155Tyr; NM_001197104.2), and provide a focused literature review of this specific variant. WSS (OMIM#605130) is a rare neurodevelopmental disorder caused by heterozygous variants in the KMT2A gene, which encodes a histone H3 lysine K4 (H3K4) methyltransferase involved in transcriptional regulation. Clinically, the syndrome is characterized by developmental delay, distinctive facial features, short stature, hypertrichosis, and neurological manifestations such as hypotonia and seizures. In this single-patient report, we describe additional clinical findings, including interstitial lung disease and hypertrophic pyloric stenosis requiring surgical intervention. These may represent rare manifestations of WSS that require confirmation in further reports before a formal expansion of the phenotypic spectrum can be established. Most pathogenic KMT2A variants arise de novo and are typically nonsense or frameshift; however, missense variants have also been reported and may have complex functional consequences. Haploinsufficiency is considered the primary pathogenic mechanism, leading to the disruption of chromatin modification and transcriptional regulation. While emerging genotype–phenotype correlations are being identified, considerable variability remains. Given the single-patient nature of this study, these observations should be considered hypothesis-generating and require confirmation in additional cases.
- 7 May 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (10) , 4163
Open AccessWiedemann–Steiner Syndrome (WSS): A Neonatal Case Report Expanding the Phenotypic Spectrum of a Previously Reported Missense Variant
We present a neonatal case of Wiedemann–Steiner syndrome (WSS) with a de novo, previously reported KMT2A missense variant (c.3464G>A; p.Cys1155Tyr; NM_001197104.2), and provide a focused literature review of this specific variant. WSS (OMIM#605130) is a rare neurodevelopmental disorder caused by heterozygous variants in the KMT2A gene, which encodes a histone H3 lysine K4 (H3K4) methyltransferase involved in transcriptional regulation. Clinically, the syndrome is characterized by developmental delay, distinctive facial features, short stature, hypertrichosis, and neurological manifestations such as hypotonia and seizures. In this single-patient report, we describe additional clinical findings, including interstitial lung disease and hypertrophic pyloric stenosis requiring surgical intervention. These may represent rare manifestations of WSS that require confirmation in further reports before a formal expansion of the phenotypic spectrum can be established. Most pathogenic KMT2A variants arise de novo and are typically nonsense or frameshift; however, missense variants have also been reported and may have complex functional consequences. Haploinsufficiency is considered the primary pathogenic mechanism, leading to the disruption of chromatin modification and transcriptional regulation. While emerging genotype–phenotype correlations are being identified, considerable variability remains. Given the single-patient nature of this study, these observations should be considered hypothesis-generating and require confirmation in additional cases.